Plasmin inhib 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TS23 / Translational Sciences
NAIL-IT, NCT05408546: Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi () Trial

Recruiting
2
32
US
TS23, Placebo
Translational Sciences, Inc.
Pulmonary Embolism
07/24
09/24
SISTER, NCT05948566: Strategy for Improving Stroke Treatment Response

Recruiting
2
300
US
TS23
Translational Sciences, Inc., University of Cincinnati, National Institute of Neurological Disorders and Stroke (NINDS), Medical University of South Carolina, University of Arizona
Ischemic Stroke
07/27
12/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TS23 / Translational Sciences
NAIL-IT, NCT05408546: Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi () Trial

Recruiting
2
32
US
TS23, Placebo
Translational Sciences, Inc.
Pulmonary Embolism
07/24
09/24
SISTER, NCT05948566: Strategy for Improving Stroke Treatment Response

Recruiting
2
300
US
TS23
Translational Sciences, Inc., University of Cincinnati, National Institute of Neurological Disorders and Stroke (NINDS), Medical University of South Carolina, University of Arizona
Ischemic Stroke
07/27
12/27

Download Options